Translatable gene therapy for lung cancer using Crispr CAS9—an exploratory review

J Nair, A Nair, S Veerappan, D Sen - Cancer gene therapy, 2020 - nature.com
Gene therapy using CRISPR Cas9 technique is rapidly gaining popularity among the
scientific community primarily because of its versatility, cost-effectiveness, and high efficacy …

CRISPR and KRAS: a match yet to be made

G Bender, R Fahrioglu Yamaci, B Taneri - Journal of biomedical science, 2021 - Springer
CRISPR (clustered regularly interspaced short palindromic repeats) systems are one of the
most fascinating tools of the current era in molecular biotechnology. With the ease that they …

Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4

K Lundø, O Dmytriyeva, L Spøhr, E Goncalves-Alves… - BMC cancer, 2023 - Springer
Background The lactate receptor GPR81 contributes to cancer development through unclear
mechanisms. Here, we investigate the roles of GPR81 in three-dimensional (3D) and in vivo …

PP2A-Mediated GSK3β Dephosphorylation Is Required for Protocadherin-7-dependent regulation of small GTPase RhoA in Osteoclasts

H Kim, N Takegahara, Y Choi - Cells, 2023 - mdpi.com
Protocadherin-7 (Pcdh7) is a member of the non-clustered protocadherin δ1 subgroup of the
cadherin superfamily. Pcdh7 has been revealed to control osteoclast differentiation by …

Post-ingestion conversion of dietary indoles into anticancer agents

LP Lin, D Liu, JC Qian, L Wu, Q Zhao… - National Science …, 2022 - academic.oup.com
There are health benefits from consuming cruciferous vegetables that release indole-3-
carbinol (I3C), but the in vivo transformation of I3C-related indoles remains …

[HTML][HTML] Nuclear translocation of cleaved PCDH9 impairs gastric cancer metastasis by downregulating CDH2 expression

Y Zhang, Y Zhu, Y Chen, Y Wang, B Liu, Y Pan, X Liao… - Iscience, 2024 - cell.com
Summary Loss of Protocadherin 9 (PCDH9) is associated with the metastasis and the
prognosis of gastric cancer patients, while the molecular mechanism of PCDH9-impaired …

Mosaic RASopathy due to KRAS variant G12D with segmental overgrowth and associated peripheral vascular malformations

VF Schmidt, I Wieland, WA Wohlgemuth… - American Journal of …, 2021 - Wiley Online Library
Oncogenic RAS variants lead to constitutive overactivation and increased signal
transduction into downstream pathways. They are found as somatic driver events in various …

[HTML][HTML] The predictive prognostic values of CBFA2T3, STX3, DENR, EGLN1, FUT4, and PCDH7 in lung cancer

Y Chen, L Shen, B Chen, X Han, Y Yu… - Annals of …, 2021 - ncbi.nlm.nih.gov
Background Lung cancer is one of the most malignant tumors. However, neither the
pathogenesis of lung cancer nor the prognosis markers are completely clear. The purpose of …

Targeting KRASG12D mutation in non-small cell lung cancer: molecular mechanisms and therapeutic potential

Y Tang, X Pu, X Yuan, Z Pang, F Li, X Wang - Cancer Gene Therapy, 2024 - nature.com
Lung malignant tumors are a type of cancer with high incidence and mortality rates
worldwide. Non-small cell lung cancer (NSCLC) accounts for over 80% of all lung malignant …

A more novel and powerful prognostic gene signature of lung adenocarcinoma determined from the immune cell infiltration landscape

C Ma, F Li, Z He, S Zhao - Frontiers in Surgery, 2022 - frontiersin.org
Background Lung adenocarcinoma (LUAD) is the leading histological subtype of lung
cancer worldwide, causing high mortality each year. The tumor immune cell infiltration (ICI) …